The home of the Audio Journal of Oncology

Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy

AudioMedica News
AudioMedica News
Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy
Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy
/

&t

Margaret Johnson
Margaret Johnson

;em>REFERENCE: Lancet 2007; 370:39-48
MARGARET JOHNSON, Royal Free Hospital, London
A new non-nucleoside reverse-transcriptase inhibitor has demonstrated its activity in patients infected with HIV-1. TMC125, or etravirine, was compared with placebo in over 500 treatment-experienced patients in the DUET-2 trial, and Derek Thorne heard more from Margaret Johnson of the Royal Free Hospital in London.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070808margaret_johnson.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality